Discover and read the best of Twitter Threads about #nyacp
Most recents (1)
1/ #NYACP #Tweetorial
#MedTwitter, let’s start with a ❓
56 yo man with type 2 diabetes mellitus and CAD for 7 years has a A1C 8.0%, and albumin:creatinine ratio 300. Which add-on diabetes med will have a protective effect on his cardiac comorbidities?
@MedTweetorials
#MedTwitter, let’s start with a ❓
56 yo man with type 2 diabetes mellitus and CAD for 7 years has a A1C 8.0%, and albumin:creatinine ratio 300. Which add-on diabetes med will have a protective effect on his cardiac comorbidities?
@MedTweetorials
2/ That’s right- Canagliflozin!
In this tweetorial we address: Why are we optimistic about SGLT2 inhibitors?
♦️ The -flozins let glucose “flow out: of proximal convoluted tubules of nephrons
♦️ Half of filtered glucose is excreted- more than 💯g in T2DM patients
#flozinate
In this tweetorial we address: Why are we optimistic about SGLT2 inhibitors?
♦️ The -flozins let glucose “flow out: of proximal convoluted tubules of nephrons
♦️ Half of filtered glucose is excreted- more than 💯g in T2DM patients
#flozinate
3/ Okay, they work for T2DM. But so do all7⃣of our first line agents! Why all the hype?
SGLTi also:
✅ ⬇️ risk of cardiovascular mortality in chronic and decompensated failure
✅ Slow progression of diabetic and non-diabetic kidney disease
✅ Induce weight loss ⚖️
SGLTi also:
✅ ⬇️ risk of cardiovascular mortality in chronic and decompensated failure
✅ Slow progression of diabetic and non-diabetic kidney disease
✅ Induce weight loss ⚖️
